Wall Street analysts’ outlook for Origin Materials Inc. (ORGN)

Origin Materials Inc. (NASDAQ: ORGN) stock fell -0.68% on Monday to $1.46 against a previous-day closing price of $1.47. With 1.06 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.88 million shares. The 52-week range on ORGN shows that it touched its highest point at $6.26 and its lowest point at $1.18 during that stretch. It currently has a 1-year price target of $4.40. Beta for the stock currently stands at 1.38.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ORGN was down-trending over the past week, with a drop of -5.19%, but this was up by 5.04% over a month. Three-month performance dropped to -66.74% while six-month performance fell -62.94%. The stock lost -75.09% in the past year, while it has lost -68.33% so far this year. A look at the trailing 12-month EPS for ORGN yields 0.20 with Next year EPS estimates of -0.43. For the next quarter, that number is -0.13. This implies an EPS growth rate of 85.60% for this year and -87.00% for next year.

Float and Shares Shorts:

At present, 139.26 million ORGN shares are outstanding with a float of 111.80 million shares on hand for trading. On Aug 30, 2023, short shares totaled 7.06 million, which was 4.92% higher than short shares on Jul 30, 2023. In addition to Mr. John Bissell as the firm’s Co-Founder, Co-CEO & Director, Mr. Richard J. Riley serves as its Co-CEO & Director.

Institutional Ownership:

Through their ownership of 29.60% of ORGN’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 20.88% of ORGN, in contrast to 17.49% held by mutual funds. Shares owned by individuals account for 11.06%. As the largest shareholder in ORGN with 4.95% of the stake, BlackRock Fund Advisors holds 7,106,570 shares worth 7,106,570. A second-largest stockholder of ORGN, BNP Paribas Asset Management UK L, holds 6,546,523 shares, controlling over 4.56% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in ORGN, holding 5,645,908 shares or 3.93% stake. With a 4.77% stake in ORGN, the BNP Paribas Funds – Energy Transi is the largest stakeholder. A total of 6,843,307 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.11% of ORGN stock, is the second-largest Mutual Fund holder. It holds 3,032,849 shares valued at 4.16 million. iShares Russell 2000 ETF holds 1.63% of the stake in ORGN, owning 2,336,548 shares worth 3.2 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, ORGN reported revenue of $0.00 and operating income of -$8.67M. The EBITDA in the recently reported quarter was $27.02M and diluted EPS was $0.33.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ORGN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ORGN analysts setting a high price target of $10.00 and a low target of $2.00, the average target price over the next 12 months is $4.40. Based on these targets, ORGN could surge 584.93% to reach the target high and rise by 36.99% to reach the target low. Reaching the average price target will result in a growth of 201.37% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded ORGN stock several times over the past three months with 9 Buys and 2 Sells. In these transactions, 660,628 shares were bought while 34,633 shares were sold. The number of buy transactions has increased to 33 while that of sell transactions has risen to 17 over the past year. The total number of shares bought during that period was 2,406,469 while 696,605 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *